Behind the Bell: Adaptive Biotechnologies

Published

Chad Robins, CEO and Co-founder at Adaptive Biotechnologies, joins us after opening the markets for a talk about newly Nasdaq-listed Adaptive's innovations.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now